Clinical Trial Update: Albumin To Enhance Recovery After Acute Kidney Injury [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous albumin to enhance recovery after acute kidney injury; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Albumin

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Acute Kidney Injury, Renal Replacement Therapy | Phase 4 | Status: RECRUITING